switch to tirzepatide from semaglutide Comment about you’re experience if you’ve switched GLP-1’s! 👀📈 See you in the comments! 🫶🏼🫶🏼🫶🏼 Next video is switching Semaglutide. #glp1community #doctorsofinstagram Early Dose Escalation of Tirzepatide

Key takeaways include beginning at the lowest dose of the new medication, allowing time for the body to adjust, and maintaining close monitoring for both glucose control and side effects

Nicolau, J., Blanco-Anesto, J., Bonet, A., Flix-Jaume, J

Nat Protoc 7(6):10091014

Right now, some have to come off the medications due to prohibitive costs and benefits running out, he says

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion

Clinical Research Synthesis A Semaglutide is a long-acting GLP-1 receptor agonist widely used as a reference incretin in studies of appetite control, gastric emptying, insulin/glucagon balance, glycemic control, and cardiometabolic risk